Cleared Traditional

K932533 - SMARTSCOPE

K932533 is an FDA 510(k) clearance for SMARTSCOPE, manufactured by Insight Medical Corp.. The device is a Class 2 Neurology device with product code JXE cleared through the Traditional 510(k) pathway after a 309-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1994
Decision
309d
Days
Class 2
Risk

K932533 is an FDA 510(k) clearance for the SMARTSCOPE. Classified as Device, Nerve Conduction Velocity Measurement (product code JXE), Class II - Special Controls.

Submitted by Insight Medical Corp. (Toronto, Ontario, CA). The FDA issued a Cleared decision on March 31, 1994 after a review of 309 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1550 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K932533

510(k) Number K932533 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 26, 1993
Decision Date March 31, 1994
Days to Decision 309 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
160d slower than avg
Panel avg: 149d · This submission: 309d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JXE Device Classification - Class 2, Special Controls

Product Code JXE Device, Nerve Conduction Velocity Measurement
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - JXE Device, Nerve Conduction Velocity Measurement

All 26
Devices cleared under the same product code (JXE) and FDA review panel - the closest regulatory comparables to K932533.
NERVEPACE(R) NERVE CONDUCTION VIEWSCOPE (200VS)
K963208 · Neurotron Medical · Jul 1997
INSTA-NERVE(TM) NERVE CONDUCTION MONITOR
K935298 · Insta Nerve Canada, Inc. · Aug 1994
TD50 ELECTROMYOGRAPH
K935017 · Medelec Intl. Corp. · Jul 1994
REUSABLE DUAL DISC BAR RECORDING ELECTRODES
K923665 · Chalgren Enterprises, Inc. · Oct 1992
REUSABLE DUAL DISC BAR ELECTRODES, VARIOUS MODELS
K921504 · Chalgren Enterprises, Inc. · Sep 1992
SENSORY NERVE CONDUCTION VELOCITY TESTING UNIT
K904165 · Occupational Preventive Diagnostics, Inc. · May 1991